News

The respiratory monitoring devices market is projected to witness significant growth from 2024 to 2030, driven by factors such as the increasing prevalence of respiratory disorders, a growing number of risk factors, and an expanding elderly population vulnerable to respiratory diseases.

DelveInsight’s Respiratory Monitoring Devices Market Insights report offers a comprehensive analysis of the current and future market landscape, including market shares of leading companies, challenges, drivers, barriers, trends, and key players in the respiratory monitoring devices market.

Key Highlights from the Respiratory Monitoring Devices Market Report:

According to DelveInsight, North America is expected to lead the global respiratory monitoring devices market during the forecast period.

Among the product types, spirometers held a significant market share in 2023.
Prominent companies in the market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Siemens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher & Paykel Healthcare, and others.

In February 2024, Masimo announced FDA clearance for the MightySat® Medical, the first and only FDA-cleared medical fingertip pulse oximeter available over-the-counter without a prescription, featuring Masimo SET® pulse oximetry.

In September 2023, Alveofit (Roundworks Technologies) received FDA approval for its portable digital spirometer, alveoair, which is part of an ecosystem providing real-time insights and predictive analytics to healthcare professionals for enhanced respiratory care.

To explore more highlights from the respiratory monitoring devices market, refer to the Global Respiratory Monitoring Devices Market Report.

Respiratory monitoring devices are vital in assessing and managing patients’ respiratory health by measuring parameters like respiratory rate, oxygen saturation (SpO2), and carbon dioxide levels. Widely used in hospitals, clinics, and home care settings, these devices are crucial for tracking respiratory function in patients with chronic conditions such as asthma, COPD, and sleep apnea. Common respiratory monitoring devices include pulse oximeters, capnographs, and spirometers, which aid in early detection of respiratory issues, enabling timely interventions and improving patient outcomes, especially in critical care settings.

Technological advancements have made respiratory monitoring devices more portable, user-friendly, and accurate. Innovations such as wearable devices and mobile-integrated solutions are gaining traction, offering continuous, non-invasive monitoring that facilitates condition management outside clinical settings. These advancements provide real-time data that can be shared with healthcare providers, allowing personalized care and enhancing the quality of life for individuals with respiratory disorders.

Source: DelveInsight